GC
SOLV icon

Grimes & Company’s Solventum SOLV Stock Holding History

Grimes & Company’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,009
Closed -$220K – 487
2025
Q3 		$220K Hold
3,009
– – 0.01% 429
2025
Q2 		$228K Buy
3,009
+100
+3% +$7.08K 0.01% 385
2025
Q1 		$221K Buy
+2,909
New +$217K 0.01% 343

Other funds holding SOLV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Grimes & Company's SOLV Position: Q4 2025 in Review

Grimes & Company sold out of Solventum (SOLV) in Q4 2025, closing a stake of 3,009 shares — an estimated $220K sold.

Grimes & Company first reported a position in SOLV in Q1 2025 and held it in 3 quarters. The position peaked at $228K in Q2 2025. 941 funds tracked by Wall St. Rank hold SOLV as of Q4 2025.

  • Grimes & Company reported no remaining Solventum position as of Q4 2025 after selling out during the quarter.
  • Grimes & Company sold 3,009 Solventum shares in Q4 2025, an estimated $220K.
  • Grimes & Company first reported a position in Solventum in Q1 2025 and held it in 3 quarters.
  • Grimes & Company's Solventum position peaked at $228K in Q2 2025.
  • 941 funds tracked by Wall St. Rank held Solventum as of Q4 2025.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.